4

OWNERSHIP DOCUMENT

Company: BRAINSTORM CELL THERAPEUTICS INC.
Filed: May 1, 2023
Period of Report: May 1, 2023
Accession Number: 0001104659-23-054393

View Document ↗ View on SEC.gov ↗